1-4 of 4
Nicola di Rienzo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Baseline Characteristics from Arise Study, an Italian Non-Interventional Study Assessing the Real-World Use of Acalabrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)

Francesca Romana Mauro, Andrea Visentin, Luca Laurenti, Susanna Gallo, Vincenzo Pavone, Paolo Nicoli, Massimiliano Postorino, Ilaria Scortechini, Lydia Scarfo, Myriam Foglietta, Chiara Borella, Gaetano Palumbo, Nicola Di Rienzo, Monica Tani, Agostino Tafuri, Paolo Sportoletti, Potito Rosario Scalzulli, Elsa Pennese, Domenico Pastore, Cristina Pasquini, Luigi Malandruccolo, Ambra Di Veroli, Gaetano De Santis, Gioacchino Catania, Anna Tamburini, Caterina Stelitano, Fabrizio Pane, Pellegrino Musto, Massimo Magagnoli, Giovanni D'Arena, Daniele Caracciolo, Deborah Bongiovanni, Gianluigi Reda, Claudia Padrone, Massimo Gentile
Journal: Blood
Blood (2024) 144 (Supplement 1): 7747.
https://doi.org/10.1182/blood-2024-199041
Published: 2024
Journal Articles

Association of Hypomethylating Agents + Venetoclax in the Real-Life Treatment of Myeloproliferative Neoplasms in Blastic Phase

Roberto Latagliata, Gianluca Cristiano, Dorela Lame, Alda Strazimiri, Fabrizio Cavalca, Lorenzo Rizzo, Giulia De Luca, Simone Zoletto, Vincenzo Federico, Daniele Cattaneo, Annalisa Biagi, Monica Crugnola, Pasquale Niscola, Raffaele Palmieri, Anna Lina Piccioni, Olga Mulas, Beatrice Esposito Vangone, Michelina Santopietro, Ida Carmosino, Alessandra Iurlo, Nicola Di Rienzo, Gianni Binotto, Prassede Salutari, Marta Riva, Massimiliano Bonifacio, Elena Maria Elli, Antonio Curti, Antonella Poloni
Journal: Blood
Blood (2023) 142 (Supplement 1): 1842.
https://doi.org/10.1182/blood-2023-190091
Published: 2023
Journal Articles

Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Therapy of Acute Myeloid Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Roberto Latagliata, Benedetta Cambò, Anna Lina Piccioni, Vincenzo Federico, Gianluca Cristiano, Elisabetta Lugli, Lorenzo Rizzo, Michelina Santopietro, Carla Mazzone, Massimiliano Bonifacio, Raffaele Palmieri, Antonella Poloni, Annalisa Biagi, Gianni Binotto, Marzia Delfina, Mario Annunziata, Alfredo Molteni, Monica Piedimonte, Ida Carmosino, Ambra Di Veroli, Pasquale Niscola, Marta Riva, Isabella Capodanno, Antonio Curti, Nicola Di Rienzo, Susanna Fenu, Monica Crugnola
Journal: Blood
Blood (2023) 142 (Supplement 1): 6497.
https://doi.org/10.1182/blood-2023-186085
Published: 2023
Journal Articles

Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial

Adriano Venditti, Alfonso Piciocchi, Stefano Soddu, Marco Frigeni, Raffaele Palmieri, Erika Borlenghi, Nicola Fracchiolla, Maria Paola Martelli, Ernesta Audisio, Giacomo Gianfaldoni, Calogero Vetro, Nicola di Rienzo, Daniela Esposito, Ambra Di Veroli, Carmine Selleri, Federica Gigli, Antonio Curti, Antonino Mulè, Catello Califano, Sara Bigliardi, Massimo Breccia, Claudio Fozza, Monica Bocchia, Albana Lico, Federico Simonetti, Elisabetta Pierdomenico, Francesco Buccisano, Maria Ilaria Del Principe, Luca Maurillo, Paola Fazi, Marco Vignetti, Felicetto Ferrara, Roberto Cairoli, Giuseppe Rossi, Alessandro Rambaldi
Journal: Blood
Blood (2023) 142 (Supplement 1): 1514.
https://doi.org/10.1182/blood-2023-178505
Published: 2023